Shahabi, The clinical relevance of rising CA-125 levels within the normal range in patients with uterine papillary se- rous cancer, Reprod. Sci. 20 (4) (2013) 449-455.The clinical relevance of rising CA-125 levels within the normal range in patients with uterine papillary serous cancer. ...
During disease progression, 3 of 4 patients had elevated serum markers such as carcinoembryonic antigen (CEA), CA19-9, CA15-3, CA125, neuron-specific enolase and pro-gastrin releasing peptide. Immunohistochemical examination of the initial biopsy specimens revealed that 4 and 3 cases were positive...
Clinical implications of a rising serum CA-125 within the normal range in patients with epithelial ovarian cancer: a preliminary investigation. Gynecol Oncol. 2003; 89 :233–235.Wilder JL, Pavlik E, Straughn JM, Kirby T, Higgins RV, DePriest PD, Ueland FR, Kryscio RJ, Whitley RJ, Nagell...
Implications of rising serum ca125 within normal range in patients with epithelial ovarian cancers : review articleNo Abstract. Obstetrics & Gynaecology Forum Vol. 17 (2) 2007: pp.55-59doi:10.4314/OGF.V17I2.30567Mouton, A.Obstetrics & Gynaecology Forum...
Whole body PET with FDG is useful for following up an ovarian cancer patient with only rising CA125 levels with in the norm al range[J].Annals of Nuclear Medicine,2002,(07):491-493.Kurokawa T, Yoshida Y, Kawahara K, Tsuchida T, Fujibayashi Y, Yonekura Y, et al. Whole-body PET ...
Despite subsequently treatment, all cases died of prostate cancer at 2, 8, 9 and 38 months. During disease progression, 3 of 4 patients had elevated serum markers such as carcinoembryonic antigen (CEA), CA19-9, CA15-3, CA125, neuron-specific enolase and pro-gastrin releasing peptide. ...